Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019-Reference-Cited by-同舟云学术

Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019

Published:2022-04-13 Issue:7 Volume:96 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Allen James D.¹^ORCID,Ross Ted M.¹²^ORCID

Affiliation:

1. Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA

2. Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA

Abstract

Standard-of-care influenza virus vaccines are composed of a mixture of antigens from different influenza viral subtypes. For the first time, lead COBRA H1 and H3 HA antigens, formulated as a bivalent vaccine, have been investigated in animals with preexisting immunity to influenza viruses.

Funder

Georgia Research Alliance

HHS | National Institutes of Health

University of Georgia

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jvi.01652-21

Reference69 articles.

1. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study